Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
29%
Atorvastatin
9%
Biological Marker
6%
Cerebrovascular Accident
25%
Cholesterol Derivative
12%
Clarithromycin
25%
Clinical Pharmacokinetics
52%
Clinical Pharmacology
16%
Clinical Study
20%
Clinical Trial
25%
Cohort Study
6%
CYP1A2
11%
CYP2C19
13%
CYP2C9
17%
CYP2D6
13%
CYP3A
7%
CYP3A4
77%
Cytochrome P450
54%
Cytokine
19%
Dicloxacillin
50%
Direct Oral Anticoagulant
25%
Disease
25%
Drug Metabolism
100%
Drug Metabolizing Enzyme
32%
Drug Screening
25%
Drug Transport
25%
Drug-Drug Interaction
17%
Flucloxacillin
55%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
25%
Inflammation
69%
Inflammatory Arthritis
27%
Inflammatory Disease
7%
Interleukin 6
34%
Interleukin 6 Receptor
8%
Messenger RNA
14%
Metformin
9%
Mevinolin
9%
Midazolam
18%
Non Insulin Dependent Diabetes Mellitus
27%
Normal Human
25%
P-Glycoprotein
31%
Pharmacokinetics
10%
Receptor Antagonist
27%
Restless Legs Syndrome
25%
Retrospective Study
14%
Rheumatoid Arthritis
27%
Selective Serotonin Reuptake Inhibitor
25%
Simvastatin
9%
Statin (Protein)
18%
Warfarin
58%
Biochemistry, Genetics and Molecular Biology
Clinical Pharmacology
16%
Clinical Trial
25%
CYP3A
7%
Drug Interaction
9%
Drug Metabolism
25%
Drug Screening
25%
Glycemic Control
8%
Interaction Study
6%
Pharmacokinetics
33%
Sex Ratio
8%
